BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19916050)

  • 1. Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions.
    Wenzel J; Zeisig R; Fichtner I
    Clin Exp Metastasis; 2010; 27(1):25-34. PubMed ID: 19916050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
    Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
    Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation.
    Wenzel J; Zeisig R; Haider W; Habedank S; Fichtner I
    Breast Cancer Res Treat; 2010 May; 121(1):13-22. PubMed ID: 19548083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation.
    Wenzel J; Zeisig R; Fichtner I
    Int J Pharm; 2009 Mar; 370(1-2):121-8. PubMed ID: 19100823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation.
    Okoshi H; Hakomori S; Nisar M; Zhou QH; Kimura S; Tashiro K; Igarashi Y
    Cancer Res; 1991 Nov; 51(22):6019-24. PubMed ID: 1657377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet deficiency in Tpo
    Thiele W; Rothley M; Dimmler A; Bugert P; Salomó Coll C; Sleeman JP
    Clin Exp Metastasis; 2018 Oct; 35(7):679-689. PubMed ID: 30043083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.
    Amirkhosravi A; Mousa SA; Amaya M; Blaydes S; Desai H; Meyer T; Francis JL
    Thromb Haemost; 2003 Sep; 90(3):549-54. PubMed ID: 12958625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.
    Rausch MP; Hahn T; Ramanathapuram L; Bradley-Dunlop D; Mahadevan D; Mercado-Pimentel ME; Runyan RB; Besselsen DG; Zhang X; Cheung HK; Lee WC; Ling LE; Akporiaye ET
    Anticancer Res; 2009 Jun; 29(6):2099-109. PubMed ID: 19528470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis.
    Blazejczyk A; Switalska M; Chlopicki S; Marcinek A; Gebicki J; Nowak M; Nasulewicz-Goldeman A; Wietrzyk J
    J Exp Clin Cancer Res; 2016 Jul; 35(1):110. PubMed ID: 27412454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of L-arginine and cilostazol on activation of platelets in vitro].
    Zhou J; Liu JH; Xing YC; Wang DM; Ouyang XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1079-83. PubMed ID: 17956695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Therapy with DETA/NO and Clopidogrel Inhibits Metastasis in Murine Mammary Gland Cancer Models via Improved Vasoprotection.
    Porshneva K; Papiernik D; Psurski M; Nowak M; Matkowski R; Ekiert M; Milczarek M; Banach J; Jarosz J; Wietrzyk J
    Mol Pharm; 2018 Nov; 15(11):5277-5290. PubMed ID: 30234992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extract of Caulis Spatholobi, a novel blocker targeting tumor cell‑induced platelet aggregation, inhibits breast cancer metastasis.
    Chen X; Li Q; Kan XX; Wang YJ; Li YJ; Yang Q; Xiao HB; Chen Y; Weng XG; Cai WY; Zhu XX
    Oncol Rep; 2016 Dec; 36(6):3215-3224. PubMed ID: 27779702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.
    Marshall JC; Collins JW; Nakayama J; Horak CE; Liewehr DJ; Steinberg SM; Albaugh M; Vidal-Vanaclocha F; Palmieri D; Barbier M; Murone M; Steeg PS
    J Natl Cancer Inst; 2012 Sep; 104(17):1306-19. PubMed ID: 22911670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent interactions of blood platelets and cancer cells, accompanied by extramedullary hematopoiesis, lead to increased platelet activation and reactivity in a mouse orthotopic model of breast cancer - implications for pulmonary and liver metastasis.
    Kassassir H; Karolczak K; Siewiera KM; Wojkowska DW; Braun M; Watala CW
    Aging (Albany NY); 2020 Mar; 12(6):5091-5120. PubMed ID: 32191918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells.
    Zhang Y; Unnithan RVM; Hamidi A; Caja L; Saupe F; Moustakas A; Cedervall J; Olsson AK
    FASEB J; 2019 Jul; 33(7):7822-7832. PubMed ID: 30912981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic characterization of early lung response to breast cancer metastasis in mice.
    Kurpińska A; Suraj J; Bonar E; Zakrzewska A; Stojak M; Sternak M; Jasztal A; Walczak M
    Exp Mol Pathol; 2019 Apr; 107():129-140. PubMed ID: 30763573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
    Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis.
    Kunita A; Kashima TG; Morishita Y; Fukayama M; Kato Y; Tsuruo T; Fujita N
    Am J Pathol; 2007 Apr; 170(4):1337-47. PubMed ID: 17392172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol.
    Kariyazono H; Nakamura K; Shinkawa T; Yamaguchi T; Sakata R; Yamada K
    Thromb Res; 2001 Mar; 101(6):445-53. PubMed ID: 11323002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
    Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I
    Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.